Stories

By Angela Yeager March 03, 2026

New research from OHSU points to an unexpected player in cancer research: nerves.

By Kari Hastings February 20, 2026

Plan developed by OHSU, OHA offers five areas of focus: liver, breast, colorectal and lung cancers, boosting HPV vaccination rates.

By Kari Hastings February 19, 2026

New national guidelines dispel myth that physical activity is too risky for older patients, survivors.

By OHSU Communications January 26, 2026

Joel Helmke, M.H.A., has been selected to serve as chief executive officer of the Knight Cancer Group.

By Cheryl Rose January 05, 2026

The Community Partnership Program invests in programs across Oregon designed by local communities, for local communities.

By Angela Yeager December 29, 2025

Scientists identified a new drug combination that could overcome treatment resistance in acute myeloid leukemia.

By Kari Hastings December 26, 2025

OHSU radiation oncologist presents promising study findings, launches a third, Medicare-backed study.

By Nicole Rideout December 17, 2025

OHSU lab started exploring new use of the drug 30 years ago; now, it may improve techniques to measure, monitor aggressive brain tumors.

By Dustin Hawes December 12, 2025

Matt Hazard received personalized, multidisciplinary care at OHSU that allowed him to overcome cancer, inspire others to get colonoscopies.

By Erik Robinson November 07, 2025

Could someday also be useful in treating other cancers influenced by same enzyme, such as glioma, pancreatic cancer, thyroid carcinoma.

Knight Cancer Institute Stories